MetaCap

SELLAS Life Sciences Group Statistics

NASDAQ: SLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.66-1.20 (-8.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SELLAS Life Sciences Group by the numbers

SELLAS Life Sciences Group has a market capitalization of $2.78 billion based on 203.86M shares outstanding. With trailing EPS of $-0.20, SELLAS Life Sciences Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.4% above its 50-day average and 50.9% above its 200-day average.

Average daily trading volume is 9.64M shares, or about $131.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SLS valuation vs. peer median

SLS compared with the median of 8 peer companies
MetricSLSPeer medianDifference
Market cap$2.78B$2.87B-3%
Avg. volume9.64M1.86M+418%

Peer median across 8 companies: TLX, DYN, ZLAB, ACAD, LEGN, XNCR, BHC, IDYA.

Valuation

Price and trading

Previous close
14.86
Open
14.97
Day range
13.39 – 15.19
52-week range
1.39 – 24.89
52-week change
+792.81%
Beta
—
Volume
15.37M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
2.78B
Forward Pe
-55.76
Eps
-0.20
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
24.89
Week52 Low
1.39
Avg Volume
9.64M
Shares Outstanding
203.86M
Ma50
11.16
Ma200
9.05
Earnings Date
Nov 12, 2026
Pct From52w High
-45.12%
Pct From52w Low
882.73%

Related